ask="N/A"
ask_size="N/A"
average_daily_volume="182735"
bid="N/A"
bid_size="N/A"
book_value="1.38"
change="N/A"
change_from_200_day_moving_average="-0.59"
change_from_50_day_moving_average="0.20"
change_from_52_week_high="-2.75"
change_From_52_week_low="0.98"
change_in_percent="N/A"
close="5.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.61"
ebitda="-55.83M"
eps_estimate_current_year="-1.25"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.09"
ex_dividend_date="N/A"
float_shares="42865000"
high="N/A"
high_52_weeks="8.35"
last_trade_date="2/13/2017"
last_trade_price="5.60"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="N/A"
low_52_weeks="4.62"
market_capitalization="324.46M"
moving_average_200_day="6.19"
moving_average_50_day="5.40"
name="Sorrento Therapeutics
Inc."
notes="N/A"
one_year_target_price="25.00"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-9.49%"
percent_change_from_50_day_moving_average="+3.79%"
percent_change_from_52_week_high="-32.93%"
percent_change_from_52_week_low="+21.21%"
previous_close="5.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.05"
price_per_sales="59.32"
revenue="5.47M"
shares_outstanding="57939000"
short_ratio="28.15"
stock_exchange="NCM"
symbol="SRNE"
volume="0"
weeks_range_52="4.62 - 8.35"
